Chronic low-grade inflammatory phenotype: clinical significance, causal factors and approaches to therapy
Authors:
- K. A. AitbaevKAK. A. Aitbaev
- I. T. MurkamilovIMI. T. Murkamilov
- V. V. FominVFV. V. Fomin
- I. U. AbdurakhmanovIAI. U. Abdurakhmanov
- T. F. YusupovaTYT. F. Yusupova
- F. A. YusupovFYF. A. Yusupov
- G. K. DuisheevaGDG. K. Duisheeva
- Sh. Sh. KhakimovSKSh. Sh. Khakimov
- D. S. YmankulovDYD. S. Ymankulov
- K. K. KhabibullaevKKK. K. Khabibullaev
- 3 March 2026
- journal article
- Published by Medical Informational Agency Publishers in Clinical Medicine (Russian Journal)
- Vol. 103 (12) , 877-884
Abstract
CLIP is a chronic, systemic and smoldering inflammatory condition clearly indicated by a 2–4-fold increase in serum levels of inflammatory mediators such as interleukin-6 and C-reactive protein. Many other cellular and molecular mediators of inflammation are also involved in the development of CLIP. CLIP typically occurs in older people, hence also known as aging inflammation, and is an integral part of the aging spectrum of the immune system. Causal factors may include: persistent viral infections such as chronic cytomegalovirus infection; cellular aging and the inability, in this regard, to eliminate degraded materials and waste products; dysbiosis and impaired intestinal permeability, obesity and others. A significant body of evidence suggests that CLIP is a powerful contributor to senility and many other adverse health chronic conditions associated with aging. Many inflammatory mediators and their regulatory mechanisms in CLIP can serve as potential targets for therapeutic intervention. However, the complexity of the inflammatory network should be taken into account when developing new interventional strategies for the treatment of CLIP and associated chronic conditions. Non-pharmacological interventions such as caloric restriction and exercise have beneficial effects on CLIP and its causative factors, which in turn can provide significant health benefits. Metformin and resveratrol have anti-inflammatory properties and, in this regard, may serve as promising therapeutic agents for the treatment of chronic low-grade inflammation and frailty.Keywords
This publication has 41 references indexed in Scilit:
- Age-Associated Microbial Dysbiosis Promotes Intestinal Permeability, Systemic Inflammation, and Macrophage DysfunctionCell Host & Microbe, 2017
- Metformin as a Tool to Target AgingCell Metabolism, 2016
- New advances in CMV and immunosenescenceExperimental Gerontology, 2014
- Chronic CMV infection in older women: Longitudinal comparisons of CMV DNA in peripheral monocytes, anti-CMV IgG titers, serum IL-6 levels, and CMV pp65 (NLV)-specific CD8+ T-cell frequencies with twelve year follow-upExperimental Gerontology, 2014
- Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese HumansCell Metabolism, 2011
- Association of detectable cytomegalovirus (CMV) DNA in monocytes rather than positive CMV IgG serology with elevated neopterin levels in community-dwelling older adultsExperimental Gerontology, 2011
- Associations of neutrophil and monocyte counts with frailty in community-dwelling disabled older women: Results from the Women’s Health and Aging Studies IExperimental Gerontology, 2009
- Upregulated ex vivo expression of stress-responsive inflammatory pathway genes by LPS-challenged CD14+ monocytes in frail older adultsMechanisms of Ageing and Development, 2009
- T cell subsets and mortality in older community-dwelling womenExperimental Gerontology, 2005
- Inflammatory mediators in the elderlyExperimental Gerontology, 2004